Lanean...
Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies
Ovarian cancer is the most lethal gynecological malignancy with a global five-year survival rate of 30-50%. First-line treatment involves cytoreductive surgery and administration of platinum-based small molecules and paclitaxel. These therapies were traditionally administered via intravenous infusio...
Gorde:
| Argitaratua izan da: | Adv Ther (Weinh) |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7942751/ https://ncbi.nlm.nih.gov/pubmed/33709016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adtp.202000144 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|